December 29th 2023
Our top coverage from the CHEST Annual Meeting 2023 explored various topics, including strategies to prevent air pollutant exposure and keys to achieving equity in lung cancer screenings.
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Preventive Drug Lists as Tools for Managing Asthma Medication Costs
Findings of this qualitative interview study suggest promise, but also challenges, with regard to using preventive drug lists to help families manage asthma medication costs.
Read More
Lung Microbiome Found to Predict Outcomes in Critically Ill Patients
January 29th 2020Key features of the lung microbiome (bacterial burden, enrichment with gut-associated bacteria) were found to predict outcomes in critically ill patients, representing a potential therapeutic target for the prevention and treatment of acute respiratory failure, according to study findings.
Read More
HHS Secretary Azar Issues Updates on Novel Coronavirus
January 29th 2020In a press conference, HHS secretary Alex Azar provided updates on the US government’s response to the 2019 novel coronavirus. He was joined by the director of the CDC, Robert Redfield, MD; the director of CDC’s National Center for Immunization and Respiratory Diseases, Nancy Messonnier, MD; and the director of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, Anthony Fauci, MD.
Read More
Nintedanib Exhibits Superior Cost-effectiveness to Pirfenidone for Treatment of IPF, Study Finds
January 25th 2020Researchers compared the cost-effectiveness of ninetedanib to pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) and found nintedanib to be more cost-saving than pirfenidone, according to study findings.
Read More
Surgeon General Releases New Report on Smoking Cessation
January 24th 2020The US Surgeon General, Jerome M. Adams, MD, MPH, has released the first report since 1990 that focuses solely on smoking cessation in America. Smoking accounts for the deaths of half a million Americans each year and is the leading cause of preventable disease, disability, and death in the country.
Read More
What We're Reading: Healthcare Issues to Watch; e-Cig Flavor Ban; Google AI and Breast Cancer
January 2nd 2020Five issues in healthcare were spotlighted as key developments to watch; FDA to ban all e-cig vape flavors except for menthol and tobacco; Google AI system shown to improve detection of breast cancer through mammograms.
Read More
Chemical Found in e-Cigarette Fluid Linked to Vaping-Related Respiratory Failure of Teen
November 13th 2019The fluid in e-cigarettes were associated with the near fatal respiratory failure of a teenage boy who was found to have an exaggerated immune response to one of its chemicals while vaping, according to a report published this week by doctors.
Read More
Highmark announced this week that its outcomes-based contract with AstraZeneca for the respiratory combination medication of budesonide/formoterol (Symbicort) revealed positive results in improving outcomes for those with asthma and chronic obstructive pulmonary disease (COPD).
Read More
Researchers Explore Costs of Switching to Environmentally Friendly Inhalers for Asthma
October 31st 2019Reducing the use of metered-dose inhalers for asthma could shrink the carbon footprint while achieving cost savings if less expensive brands of dry powder inhalers are used, according to new research findings.
Read More
Dr Lisa Lancaster Discusses the Overlap of Sleep Apnea and Lung Diseases
October 22nd 2019Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health, discusses how sleep apnea is a comorbidity for other lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease.
Watch
Several species of bacteria that can transmit respiratory infections have varying levels of response to the disinfecting agents used in municipal water treatment systems, with no one water disinfection strategy achieving complete microbial control, according to new findings.
Read More
High Levels of Chronic Stress, High Blood Pressure Linked in African Americans
October 16th 2019African Americans who report high levels of chronic stress were shown to be at a heightened risk of developing high blood pressure, or hypertension, with specific stressors such as discrimination and socioeconomic status serving as possible catalysts, according to study findings.
Read More
Three-in-One Inhaler Found to Improve Lung Function, Reduce Asthma Attacks in 2 Phase 3 Trials
October 3rd 2019Research presented at the European Respiratory Society Conference 2019 details the novel use of a single inhaler combining 3 therapies, as opposed to 2, in 2 clinical studies on patients with severe asthma.
Read More
Flavored E-Cigarettes Linked With Worsening Severity of Asthma in Mice
September 21st 2019Flavored e-cigarettes without nicotine were shown to have differing asthma outcomes on mice based on the flavor, indicating that some flavors may worsen the severity of allergic airways disease, according to a new study.
Read More
Individuals with HIV are often susceptible to opportunistic pulmonary infections, but the lung lesions resulting from these infections can be mistaken for lung cancer, according to a new study that aimed to characterize features of OPIs versus tumors in patients with HIV.
Read More
What We're Reading: FDA Investigating Juul; Sutter Health Handed Lawsuit; European Doctor Sues FDA
September 10th 2019Juul is being investigated for making unauthorized safety claims, while the governor of New York proposes to ban flavored e-cigarettes; Sutter Health is being sued for its role in rising healthcare costs; a European doctor who uses telemedicine and internet prescribing to provide American women with mifepristone and misoprostol to induce abortion in the first trimester is suing the FDA.
Read More